Sopharma AD plans to build the new lyophilic factory in Sofia in the first half of 2018. With the construction of the plant Sopharma AD will double the capacity of its current production facilities, which will ensure the production of sufficient quantities of the life-saving hospital product Methylprednisolone and will create additional workplaces.